

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.80205216 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.80205216 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.51917253 |
| 4 | interferon-gamma production (GO:0032609) | 6.51854245 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 6.27077495 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.07566169 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.04113591 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.02373822 |
| 9 | negative T cell selection (GO:0043383) | 6.01315584 |
| 10 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.94047671 |
| 11 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.74201605 |
| 12 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.74201605 |
| 13 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.73598151 |
| 14 | response to interleukin-15 (GO:0070672) | 5.67250681 |
| 15 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 5.56972297 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.52386278 |
| 17 | negative regulation of T cell mediated immunity (GO:0002710) | 5.44882199 |
| 18 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 5.38338307 |
| 19 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.38276273 |
| 20 | negative thymic T cell selection (GO:0045060) | 5.38109097 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 5.36471310 |
| 22 | positive T cell selection (GO:0043368) | 5.22588852 |
| 23 | positive thymic T cell selection (GO:0045059) | 5.15577814 |
| 24 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 5.10620033 |
| 25 | regulation of alpha-beta T cell proliferation (GO:0046640) | 5.04267864 |
| 26 | positive regulation of T cell cytokine production (GO:0002726) | 5.03819999 |
| 27 | regulation of T cell mediated cytotoxicity (GO:0001914) | 5.00159102 |
| 28 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.99560428 |
| 29 | positive regulation of cell killing (GO:0031343) | 4.95992244 |
| 30 | cytidine deamination (GO:0009972) | 4.95159846 |
| 31 | cytidine metabolic process (GO:0046087) | 4.95159846 |
| 32 | cytidine catabolic process (GO:0006216) | 4.95159846 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.92263613 |
| 34 | positive regulation of T cell chemotaxis (GO:0010820) | 4.87962846 |
| 35 | regulation of T cell chemotaxis (GO:0010819) | 4.87962846 |
| 36 | T cell migration (GO:0072678) | 4.85512478 |
| 37 | regulation of cell killing (GO:0031341) | 4.82590211 |
| 38 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.66036457 |
| 39 | lymphocyte chemotaxis (GO:0048247) | 4.59766637 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.55027700 |
| 41 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.51375842 |
| 42 | thymic T cell selection (GO:0045061) | 4.47505901 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46129951 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.42327403 |
| 45 | activated T cell proliferation (GO:0050798) | 4.37039289 |
| 46 | DNA deamination (GO:0045006) | 4.19811913 |
| 47 | T cell selection (GO:0045058) | 4.18240007 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 4.04295405 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.02770296 |
| 50 | negative regulation of T cell apoptotic process (GO:0070233) | 3.99968451 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.99894924 |
| 52 | lymphocyte migration (GO:0072676) | 3.99575695 |
| 53 | leukocyte aggregation (GO:0070486) | 3.99033231 |
| 54 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.94870044 |
| 55 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.93488035 |
| 56 | T cell receptor signaling pathway (GO:0050852) | 3.92865967 |
| 57 | mast cell activation (GO:0045576) | 3.91050222 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.89693312 |
| 59 | regulation of B cell differentiation (GO:0045577) | 3.82437258 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 3.81885834 |
| 61 | cellular defense response (GO:0006968) | 3.78050472 |
| 62 | positive regulation of T cell mediated immunity (GO:0002711) | 3.77867963 |
| 63 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.77718585 |
| 64 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.72259431 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 3.71424885 |
| 66 | positive regulation of granulocyte differentiation (GO:0030854) | 3.70331235 |
| 67 | positive regulation of tolerance induction (GO:0002645) | 3.69062291 |
| 68 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.68730322 |
| 69 | natural killer cell activation (GO:0030101) | 3.58896639 |
| 70 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.54517650 |
| 71 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.53351758 |
| 72 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.51112135 |
| 73 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.49708568 |
| 74 | regulation of T cell cytokine production (GO:0002724) | 3.47786894 |
| 75 | actin nucleation (GO:0045010) | 3.47075231 |
| 76 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.44594276 |
| 77 | T cell costimulation (GO:0031295) | 3.43647884 |
| 78 | regulation of T cell mediated immunity (GO:0002709) | 3.42224848 |
| 79 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.41298918 |
| 80 | lymphocyte costimulation (GO:0031294) | 3.39673762 |
| 81 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.35281770 |
| 82 | positive regulation of B cell mediated immunity (GO:0002714) | 3.35281770 |
| 83 | negative regulation of adaptive immune response (GO:0002820) | 3.34898932 |
| 84 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.33204321 |
| 85 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.30830860 |
| 86 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.30715536 |
| 87 | regulation of activation of Janus kinase activity (GO:0010533) | 3.28667577 |
| 88 | regulation of tolerance induction (GO:0002643) | 3.26859404 |
| 89 | mast cell degranulation (GO:0043303) | 3.26074325 |
| 90 | mast cell activation involved in immune response (GO:0002279) | 3.26074325 |
| 91 | regulation of T-helper 1 type immune response (GO:0002825) | 3.21659144 |
| 92 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.21156061 |
| 93 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.09778817 |
| 94 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.08916337 |
| 95 | Peyers patch development (GO:0048541) | 3.08916337 |
| 96 | regulation of alpha-beta T cell activation (GO:0046634) | 3.08906880 |
| 97 | positive regulation of interleukin-4 production (GO:0032753) | 3.06502902 |
| 98 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.05811911 |
| 99 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.03002871 |
| 100 | positive regulation of lymphocyte migration (GO:2000403) | 3.02737363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.59567108 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.58096374 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.35653375 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.82523026 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.37280103 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.02577648 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.73428409 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.51933734 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.50638627 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.32211486 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.87354312 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.62213429 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.61907369 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.49267420 |
| 15 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.46168995 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45718288 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.43371710 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38945445 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.38001407 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.17972150 |
| 21 | GATA3_26560356_Chip-Seq_TH2_Human | 2.17219541 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.11647224 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.07103773 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.05148114 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93374489 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.92932306 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85989941 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81687698 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 1.79366373 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69632470 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68169068 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.67220424 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48146007 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.43092723 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42463249 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40590945 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38903665 |
| 38 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.38565117 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36180374 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36079966 |
| 41 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34791169 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33915933 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28022855 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27571590 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22784752 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20822705 |
| 47 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18837366 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.18751818 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18448701 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17754181 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06524718 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05492862 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05013852 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03839429 |
| 55 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03359328 |
| 56 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.01900138 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00903537 |
| 58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00609285 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96959983 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95458547 |
| 61 | GATA3_26560356_Chip-Seq_TH1_Human | 0.94464671 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92590745 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92025132 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90086704 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.89706908 |
| 66 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88028789 |
| 67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86636199 |
| 68 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86602742 |
| 69 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86238409 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85780841 |
| 71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85519377 |
| 72 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.84958705 |
| 73 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84595693 |
| 74 | P300_27268052_Chip-Seq_Bcells_Human | 0.84232414 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.84230345 |
| 76 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83807583 |
| 77 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83024877 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.82816724 |
| 79 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82752671 |
| 80 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81673944 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.81619963 |
| 82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.81377963 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.80274425 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80004152 |
| 85 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.79907635 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79813744 |
| 87 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77638190 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.77528274 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75977290 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75837752 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75779079 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75562139 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72687924 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.71364708 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71056699 |
| 96 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.70534100 |
| 97 | AR_20517297_ChIP-Seq_VCAP_Human | 0.70389075 |
| 98 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70346765 |
| 99 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.70058943 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69308463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.00693447 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.40066983 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.84446811 |
| 4 | MP0009785_altered_susceptibility_to | 3.65683901 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.34027971 |
| 6 | MP0001800_abnormal_humoral_immune | 3.20741908 |
| 7 | MP0003436_decreased_susceptibility_to | 3.02258715 |
| 8 | MP0005025_abnormal_response_to | 2.92524474 |
| 9 | MP0002723_abnormal_immune_serum | 2.92072275 |
| 10 | MP0000685_abnormal_immune_system | 2.91321582 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.91181858 |
| 12 | MP0003724_increased_susceptibility_to | 2.89734589 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.89622280 |
| 14 | MP0001819_abnormal_immune_cell | 2.84189341 |
| 15 | MP0005387_immune_system_phenotype | 2.79026631 |
| 16 | MP0001790_abnormal_immune_system | 2.79026631 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.55836688 |
| 18 | MP0002006_tumorigenesis | 2.50601151 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.43267344 |
| 20 | MP0002419_abnormal_innate_immunity | 2.35785941 |
| 21 | MP0006082_CNS_inflammation | 2.32821141 |
| 22 | MP0002398_abnormal_bone_marrow | 2.28411276 |
| 23 | MP0000716_abnormal_immune_system | 2.22777482 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.21353878 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.19372645 |
| 26 | MP0004381_abnormal_hair_follicle | 2.17987990 |
| 27 | MP0003866_abnormal_defecation | 2.15375697 |
| 28 | MP0002405_respiratory_system_inflammati | 2.04707209 |
| 29 | MP0002722_abnormal_immune_system | 1.94679438 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.94147485 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.88042255 |
| 32 | MP0004947_skin_inflammation | 1.86424200 |
| 33 | MP0005075_abnormal_melanosome_morpholog | 1.82681273 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.78318375 |
| 35 | MP0003646_muscle_fatigue | 1.75793829 |
| 36 | MP0002429_abnormal_blood_cell | 1.70701531 |
| 37 | MP0003448_altered_tumor_morphology | 1.67194250 |
| 38 | MP0005310_abnormal_salivary_gland | 1.63725474 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.48050686 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.48011245 |
| 41 | MP0005377_hearing/vestibular/ear_phenot | 1.47276366 |
| 42 | MP0003878_abnormal_ear_physiology | 1.47276366 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.45100857 |
| 44 | MP0003045_fibrosis | 1.41208946 |
| 45 | MP0008469_abnormal_protein_level | 1.38143629 |
| 46 | MP0001873_stomach_inflammation | 1.33295192 |
| 47 | MP0001853_heart_inflammation | 1.32278079 |
| 48 | MP0002933_joint_inflammation | 1.31685415 |
| 49 | MP0000858_altered_metastatic_potential | 1.17893441 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.13034358 |
| 51 | MP0009764_decreased_sensitivity_to | 1.08770415 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.06171231 |
| 53 | MP0009763_increased_sensitivity_to | 1.03380971 |
| 54 | MP0005166_decreased_susceptibility_to | 0.87784028 |
| 55 | MP0002019_abnormal_tumor_incidence | 0.86823823 |
| 56 | MP0003300_gastrointestinal_ulcer | 0.85907302 |
| 57 | MP0000015_abnormal_ear_pigmentation | 0.82389838 |
| 58 | MP0004130_abnormal_muscle_cell | 0.81753780 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 0.81739771 |
| 60 | MP0002998_abnormal_bone_remodeling | 0.80315973 |
| 61 | MP0002693_abnormal_pancreas_physiology | 0.77129978 |
| 62 | MP0002009_preneoplasia | 0.75642845 |
| 63 | MP0003303_peritoneal_inflammation | 0.73020774 |
| 64 | MP0001501_abnormal_sleep_pattern | 0.71803179 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 0.71231910 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 0.70870037 |
| 67 | MP0008872_abnormal_physiological_respon | 0.67812850 |
| 68 | MP0001765_abnormal_ion_homeostasis | 0.64185510 |
| 69 | MP0003786_premature_aging | 0.63332034 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.62920102 |
| 71 | MP0004142_abnormal_muscle_tone | 0.60838344 |
| 72 | MP0002396_abnormal_hematopoietic_system | 0.59660263 |
| 73 | MP0001919_abnormal_reproductive_system | 0.59651009 |
| 74 | MP0003075_altered_response_to | 0.58190927 |
| 75 | MP0005174_abnormal_tail_pigmentation | 0.56497710 |
| 76 | MP0003183_abnormal_peptide_metabolism | 0.56240571 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.55752602 |
| 78 | MP0003690_abnormal_glial_cell | 0.54642270 |
| 79 | MP0005451_abnormal_body_composition | 0.54291538 |
| 80 | MP0005410_abnormal_fertilization | 0.52642957 |
| 81 | MP0003252_abnormal_bile_duct | 0.51961640 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 0.51368774 |
| 83 | MP0005390_skeleton_phenotype | 0.51367008 |
| 84 | MP0008873_increased_physiological_sensi | 0.51150032 |
| 85 | MP0002132_abnormal_respiratory_system | 0.50577444 |
| 86 | MP0004883_abnormal_blood_vessel | 0.50400214 |
| 87 | MP0003195_calcinosis | 0.49760820 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.49708242 |
| 89 | MP0002095_abnormal_skin_pigmentation | 0.48296697 |
| 90 | MP0009643_abnormal_urine_homeostasis | 0.46175577 |
| 91 | MP0003795_abnormal_bone_structure | 0.45854225 |
| 92 | MP0000604_amyloidosis | 0.45835838 |
| 93 | MP0002102_abnormal_ear_morphology | 0.45357461 |
| 94 | MP0001851_eye_inflammation | 0.45275006 |
| 95 | MP0000609_abnormal_liver_physiology | 0.42841018 |
| 96 | MP0000920_abnormal_myelination | 0.42620101 |
| 97 | MP0009642_abnormal_blood_homeostasis | 0.41550605 |
| 98 | MP0001905_abnormal_dopamine_level | 0.40648463 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.39868447 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.39523986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.47349207 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.88030674 |
| 3 | Optic neuritis (HP:0100653) | 5.85222683 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.85222683 |
| 5 | Myositis (HP:0100614) | 5.46172852 |
| 6 | Orchitis (HP:0100796) | 5.25769120 |
| 7 | IgG deficiency (HP:0004315) | 5.10461369 |
| 8 | Abnormality of T cells (HP:0002843) | 5.05351903 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 4.97886646 |
| 10 | Encephalitis (HP:0002383) | 4.96079810 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.85542434 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.37782680 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 4.36620147 |
| 14 | Hypoproteinemia (HP:0003075) | 4.17143044 |
| 15 | Keratoconjunctivitis (HP:0001096) | 4.14622211 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.14437756 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 4.14437756 |
| 18 | Combined immunodeficiency (HP:0005387) | 3.91773110 |
| 19 | Autoimmune hemolytic anemia (HP:0001890) | 3.89771623 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.83616493 |
| 21 | Abnormality of eosinophils (HP:0001879) | 3.81342591 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.80793854 |
| 23 | Meningitis (HP:0001287) | 3.75294945 |
| 24 | Stomatitis (HP:0010280) | 3.70177597 |
| 25 | Aplastic anemia (HP:0001915) | 3.65810268 |
| 26 | Thyroiditis (HP:0100646) | 3.61353808 |
| 27 | Increased IgM level (HP:0003496) | 3.57310850 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.55210879 |
| 29 | Recurrent bronchitis (HP:0002837) | 3.55062260 |
| 30 | Chronic diarrhea (HP:0002028) | 3.42014886 |
| 31 | Abnormality of macrophages (HP:0004311) | 3.40705548 |
| 32 | Vasculitis (HP:0002633) | 3.36029558 |
| 33 | Pulmonary infiltrates (HP:0002113) | 3.33526276 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.28009932 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 3.24364175 |
| 36 | Hemoptysis (HP:0002105) | 3.22054829 |
| 37 | Leukocytosis (HP:0001974) | 3.20518928 |
| 38 | Recurrent viral infections (HP:0004429) | 3.18891039 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 3.13045997 |
| 40 | Recurrent abscess formation (HP:0002722) | 3.05575877 |
| 41 | Eosinophilia (HP:0001880) | 3.05358901 |
| 42 | Recurrent skin infections (HP:0001581) | 3.02777766 |
| 43 | Gangrene (HP:0100758) | 3.02126734 |
| 44 | Pustule (HP:0200039) | 2.90887041 |
| 45 | Lymphopenia (HP:0001888) | 2.86710370 |
| 46 | Agammaglobulinemia (HP:0004432) | 2.85164920 |
| 47 | Arterial thrombosis (HP:0004420) | 2.83649027 |
| 48 | Pulmonary embolism (HP:0002204) | 2.82532224 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.80248391 |
| 50 | Anorexia (HP:0002039) | 2.80164187 |
| 51 | Joint swelling (HP:0001386) | 2.75103656 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.69950188 |
| 53 | Granulocytopenia (HP:0001913) | 2.67304819 |
| 54 | Keratitis (HP:0000491) | 2.65283515 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.59594793 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.59232182 |
| 57 | Hypoplasia of the thymus (HP:0000778) | 2.57514495 |
| 58 | Congenital stationary night blindness (HP:0007642) | 2.57323954 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.52435979 |
| 60 | Obstructive lung disease (HP:0006536) | 2.48072405 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48072405 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.47055243 |
| 63 | IgM deficiency (HP:0002850) | 2.46384084 |
| 64 | Abnormality of the pleura (HP:0002103) | 2.42675874 |
| 65 | Hemiplegia (HP:0002301) | 2.41259345 |
| 66 | Chest pain (HP:0100749) | 2.35994296 |
| 67 | Bronchitis (HP:0012387) | 2.33850561 |
| 68 | 3-Methylglutaconic aciduria (HP:0003535) | 2.33224455 |
| 69 | Lymphoma (HP:0002665) | 2.30819627 |
| 70 | Abnormality of B cell number (HP:0010975) | 2.28011963 |
| 71 | Acute hepatic failure (HP:0006554) | 2.23598640 |
| 72 | Glomerulopathy (HP:0100820) | 2.17773794 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.17773310 |
| 74 | Slow saccadic eye movements (HP:0000514) | 2.16152217 |
| 75 | Abnormality of the prostate (HP:0008775) | 2.15427525 |
| 76 | Stomach cancer (HP:0012126) | 2.15287404 |
| 77 | Pigmentary retinal degeneration (HP:0001146) | 2.10129564 |
| 78 | Polyneuropathy (HP:0001271) | 2.06521415 |
| 79 | Gingival bleeding (HP:0000225) | 2.05648829 |
| 80 | Colitis (HP:0002583) | 2.05533164 |
| 81 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.92320463 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91333730 |
| 83 | Acne (HP:0001061) | 1.90410550 |
| 84 | Abnormality of the pericardium (HP:0001697) | 1.88204587 |
| 85 | Increased IgE level (HP:0003212) | 1.87259767 |
| 86 | B lymphocytopenia (HP:0010976) | 1.85790085 |
| 87 | Abnormality of the endocardium (HP:0004306) | 1.85162145 |
| 88 | Vertigo (HP:0002321) | 1.84922080 |
| 89 | Renal cortical cysts (HP:0000803) | 1.84194058 |
| 90 | Epistaxis (HP:0000421) | 1.81911374 |
| 91 | Pancytopenia (HP:0001876) | 1.75897441 |
| 92 | Urticaria (HP:0001025) | 1.73177955 |
| 93 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.70676569 |
| 94 | Chronic otitis media (HP:0000389) | 1.69571719 |
| 95 | Thrombophlebitis (HP:0004418) | 1.68830783 |
| 96 | Arthralgia (HP:0002829) | 1.67277020 |
| 97 | Microcytic anemia (HP:0001935) | 1.66583775 |
| 98 | Hyperlipoproteinemia (HP:0010980) | 1.66299839 |
| 99 | Pancreatitis (HP:0001733) | 1.63217338 |
| 100 | Petechiae (HP:0000967) | 1.59231660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 8.39203883 |
| 2 | TESK2 | 3.64448843 |
| 3 | MAP4K1 | 3.62421021 |
| 4 | TAOK3 | 3.14894871 |
| 5 | KDR | 3.14277900 |
| 6 | FES | 2.55425901 |
| 7 | MAP4K2 | 2.28905793 |
| 8 | CSK | 2.28337158 |
| 9 | ITK | 2.27865178 |
| 10 | GRK6 | 2.27327701 |
| 11 | IKBKE | 2.10403994 |
| 12 | JAK3 | 1.98481451 |
| 13 | ZAP70 | 1.82571744 |
| 14 | SYK | 1.79520018 |
| 15 | RIPK4 | 1.73305655 |
| 16 | JAK1 | 1.70695747 |
| 17 | BTK | 1.70380584 |
| 18 | NEK9 | 1.69243038 |
| 19 | MAP3K11 | 1.62702889 |
| 20 | LCK | 1.59934024 |
| 21 | MAP3K14 | 1.49615984 |
| 22 | TESK1 | 1.48062635 |
| 23 | TYK2 | 1.46192758 |
| 24 | MAP3K12 | 1.42659823 |
| 25 | PASK | 1.39635303 |
| 26 | GRK7 | 1.37840559 |
| 27 | NLK | 1.31383938 |
| 28 | CAMKK2 | 1.31120739 |
| 29 | TEC | 1.29844676 |
| 30 | TLK1 | 1.29797216 |
| 31 | LYN | 1.24533451 |
| 32 | MUSK | 1.24044989 |
| 33 | PRKCQ | 1.21508856 |
| 34 | IKBKB | 1.21350302 |
| 35 | BLK | 1.19523252 |
| 36 | IRAK4 | 1.19086149 |
| 37 | TBK1 | 1.19051776 |
| 38 | CSF1R | 1.04385603 |
| 39 | TNK2 | 1.02308768 |
| 40 | ADRBK2 | 1.00616562 |
| 41 | CAMKK1 | 1.00252186 |
| 42 | HCK | 0.96986630 |
| 43 | ZAK | 0.96951417 |
| 44 | SCYL2 | 0.94344564 |
| 45 | STK10 | 0.93647784 |
| 46 | KIT | 0.84590306 |
| 47 | MAP2K3 | 0.80790080 |
| 48 | PIK3CG | 0.80537762 |
| 49 | CLK1 | 0.75169889 |
| 50 | MAP3K3 | 0.73357597 |
| 51 | MARK3 | 0.72195896 |
| 52 | JAK2 | 0.72034657 |
| 53 | BMPR2 | 0.70901686 |
| 54 | FYN | 0.70071685 |
| 55 | MST4 | 0.69602501 |
| 56 | PIM1 | 0.69152153 |
| 57 | CDK19 | 0.65462611 |
| 58 | FGR | 0.61410215 |
| 59 | TGFBR2 | 0.61270061 |
| 60 | MAP2K6 | 0.60636794 |
| 61 | MATK | 0.60064911 |
| 62 | MAPKAPK3 | 0.57560214 |
| 63 | IGF1R | 0.56687179 |
| 64 | MAPK11 | 0.56285398 |
| 65 | PDK1 | 0.54921040 |
| 66 | NUAK1 | 0.54291794 |
| 67 | MAP3K10 | 0.51347604 |
| 68 | WNK4 | 0.49620981 |
| 69 | FRK | 0.48056254 |
| 70 | NEK6 | 0.43219657 |
| 71 | MAP3K5 | 0.42934492 |
| 72 | OXSR1 | 0.41683099 |
| 73 | EPHA3 | 0.41086330 |
| 74 | GRK1 | 0.40607056 |
| 75 | SIK2 | 0.40402411 |
| 76 | INSR | 0.39542453 |
| 77 | MAP2K2 | 0.38314104 |
| 78 | MAPKAPK2 | 0.37153361 |
| 79 | EPHB1 | 0.36525184 |
| 80 | LIMK1 | 0.36002075 |
| 81 | FGFR4 | 0.34641686 |
| 82 | GRK5 | 0.34051870 |
| 83 | TAOK2 | 0.33529143 |
| 84 | TAOK1 | 0.31602448 |
| 85 | CDK4 | 0.30014358 |
| 86 | PRKCH | 0.27624171 |
| 87 | LRRK2 | 0.26756184 |
| 88 | EGFR | 0.24837566 |
| 89 | DAPK1 | 0.24557736 |
| 90 | MAPK7 | 0.24208897 |
| 91 | TRPM7 | 0.23770989 |
| 92 | ADRBK1 | 0.23528624 |
| 93 | PIK3CA | 0.22735016 |
| 94 | TYRO3 | 0.22689792 |
| 95 | FGFR3 | 0.22552355 |
| 96 | ERBB2 | 0.22441867 |
| 97 | RPS6KA5 | 0.20857417 |
| 98 | HIPK2 | 0.20688979 |
| 99 | MAP3K1 | 0.20159226 |
| 100 | SIK3 | 0.20095849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.29476742 |
| 2 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.11273566 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.99668027 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.95497967 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.48096332 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.94941005 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.94923108 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.61189819 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.56515721 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.40320377 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.35552990 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.31481386 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24532761 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.79243990 |
| 15 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.77937843 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62242901 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59505315 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57273752 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.55915348 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54194114 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53923682 |
| 22 | * Malaria_Homo sapiens_hsa05144 | 1.48226005 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.43076784 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40375516 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36851685 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36502449 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33213798 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21376498 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20714026 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13914222 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12959026 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.12690550 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09326075 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.09152832 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.06873452 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00900276 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 0.95587064 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92505270 |
| 39 | Asthma_Homo sapiens_hsa05310 | 0.88395294 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 0.87388791 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 0.86434077 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 0.84184396 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 0.74020300 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 0.73456470 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 0.72428988 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71731523 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71611781 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.69366594 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65209727 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63537965 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 0.63183324 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62934312 |
| 53 | RNA polymerase_Homo sapiens_hsa03020 | 0.62441165 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56639612 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56320187 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56050975 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53505878 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53304011 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52849018 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48826173 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.46427972 |
| 62 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44704756 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.42272277 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41600347 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40943030 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39776147 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38656063 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38335655 |
| 69 | Morphine addiction_Homo sapiens_hsa05032 | 0.35494996 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.34197773 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31891196 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31608694 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.30109073 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29706080 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28817529 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.28670935 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.27079090 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26774997 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25156988 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23483050 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23064881 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20448719 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19874908 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19739304 |
| 85 | Taste transduction_Homo sapiens_hsa04742 | 0.19522588 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19365564 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17009897 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15700227 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14989983 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14319500 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.14162454 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.14141388 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.13851622 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.13720576 |
| 95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.13639990 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.11322315 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.10859181 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09453571 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.08557107 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.08541028 |

